Team improves non-invasive visualisation of photoreceptors in eye
A new imaging technique for photoreceptors has been developed by selectively blocking light used to observe the eye.
List view / Grid view
A new imaging technique for photoreceptors has been developed by selectively blocking light used to observe the eye.
Scientists demonstrate that vitronectin is responsible of the formation of deposits in dry age-related macular degeneration and suggest inhibitors could slow disease progression.
Ophthalmology and engineering combine in a novel nanoparticle-delivered gene therapy approach to treating wet age-related macular degeneration.
The loss of retinal light-sensing photoreceptor cells is a leading cause of blindness and the number of individuals affected by retinal degenerative diseases is increasing with an ageing population. Currently, there are no treatments for these diseases and progress in finding new treatments is slow. This article explores the potential…
Scientists have implicated toll-like receptor 2 (TLR2) in age-related macular degeneration and shown that knocking it out can improve symptoms in animal models.
Researchers have discovered electrical channels important in sensory cell renewal which could be studied further to develop therapies for retinal diseases.
Scientists are one step closer to developing an eye drop that could revolutionise treatment for age-related macular degeneration (AMD)...
Older cells promote inflammation, abnormal blood vessel growth that can lead to blindness...
NIH discovery in mice could lead to therapies to reduce vision loss from diseases of the retina...
Stem cell-derived retinal cells need primary cilia to support the survival of light-sensing photoreceptors...
Researchers have used CRISPR-Cas9 to target retinal angiogenesis via an adeno-associated virus to deliver genomic edits to target vascular endothelial cell growth factor...